More evidence for shortening antibiotic therapy in peritonitis: the DURAPOP trial

Recently, Montravers et al. published the DURAPOP randomised clinical trial of duration of antimicrobial therapy for patients treated in the intensive care unit (ICU) for post-operative peritonitis (1). The investigators should be lauded for a carefully conceived and executed trial in a very challenging and sick patient population